Based on the observations that Met and Erlo additively inhibited the growth of EGFR WT A549 lung cancer cells in vitro, we examined the therapeutic effect of these two agents on the growth of xenograft tumors in immuno-compromised mice. Here, EGFR is linked to lung cancer.